Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Sulzer orders down:

This article was originally published in Clinica

Executive Summary

Sulzer Medica saw sales rise by 15% or 4% adjusted for acquisitions and currency translation, to SwFr1,183 million ($788 million). The Swiss company says that the current weakness in the US$ is unlikely to affect the 1998 results significantly. The parent company, Sulzer Technology, says that its orders dropped in the first nine months by 6%, or 4% when adjusted for currency fluctuations, to SwFr4,376 million.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT082364

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel